Today's Quality Lowdown explores what has been happening lately with US Food and Drug Administration drug good manufacturing practices import alerts.
The agency has so far in January prevented six more foreign drug manufacturing facilities from exporting their drug products to the US after FDA inspections showed they were not meeting...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?